Information  X 
Enter a valid email address

Ideagen PLC (IDEA)

  Print   

Monday 25 January, 2021

Ideagen PLC

H1 Results Presentation

RNS Number : 8154M
Ideagen PLC
25 January 2021
 

Ideagen PLC

("Ideagen"," the "Company" or the "Group'')

H1 Results Presentation

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management software to highly regulated industries, will tomorrow announce its unaudited interim results for the six months ended 31 October 2020.

The results will be accompanied by a presentation to investors and analysts at 9.00 am. The presentation will be available at the following link:

https://www.lsegissuerservices.com/spark/Ideagen/events/9999d1f2-4e47-4bf6-8c9a-f127830d1b9b  

 

A recording of the presentation and a copy of the materials will be available after the event at www.ideagenplc.com

 

Enquiries:

Ideagen plc

01629 699 100

David Hornsby, Executive Chairman


Ben Dorks, Chief Executive Officer


Emma Hayes, Chief Financial Officer

 




finnCap Limited

020 7220 0500

Henrik Persson/James Thompson/Kate Washington (Nomad)


Alice Lane (ECM)

 


Canaccord Genuity

020 7523 8000

Simon Bridges


Richard Andrews


About Ideagen plc

Ideagen is a UK-headquartered, global technology company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

A global supplier of regulatory and compliance solutions, Ideagen provides a common software platform and an integrated risk-based approach to meet multi-industry standards, enabling compliance with relevant laws, policies, and regulations.

The Group provides software and services to organisations operating within highly regulated industries such as life sciences, healthcare, banking and finance, insurance, aviation, and aerospace and defence, with its main operational premises spread throughout the UK, EU, US, Middle East and SE Asia.

Currently, more than 5,700 organisations use Ideagen's products including eight of the top 10 UK accounting firms, all of the top aerospace and defence companies and 75% of the world's leading pharmaceutical firms.

Ideagen's diverse and varied customer base includes many well-known, global brands such as British Airways, Aggreko, BAE, Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank, Meggitt, Heineken, Johnson Matthey, Haeco Group and European Central Bank. As well as this, Ideagen counts 250 hospitals across the UK and US amongst its client base. For further information please visit www.ideagen.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORFLFFRLSIEFIL

a d v e r t i s e m e n t